255 related articles for article (PubMed ID: 17174555)
21. Apolipoprotein E epsilon4 and age at onset of sporadic and familial Alzheimer disease in Caribbean Hispanics.
Olarte L; Schupf N; Lee JH; Tang MX; Santana V; Williamson J; Maramreddy P; Tycko B; Mayeux R
Arch Neurol; 2006 Nov; 63(11):1586-90. PubMed ID: 17101827
[TBL] [Abstract][Full Text] [Related]
22. Apolipoprotein E genotypes in hospitalized elderly patients with vascular dementia.
Orsitto G; Seripa D; Panza F; Franceschi M; Cascavilla L; Placentino G; Matera MG; Paris F; Capurso C; Solfrizzi V; Dallapiccola B; Pilotto A
Dement Geriatr Cogn Disord; 2007; 23(5):327-33. PubMed ID: 17374951
[TBL] [Abstract][Full Text] [Related]
23. Genetic analysis of tumor necrosis factor-alpha (TNF-alpha) G-308A and Saitohin Q7R polymorphisms with Alzheimer's disease.
Wang B; Zhou S; Yang Z; Xie YC; Wang J; Zhang P; Lv Z; Zheng C; Ma X
J Neurol Sci; 2008 Jul; 270(1-2):148-51. PubMed ID: 18396294
[TBL] [Abstract][Full Text] [Related]
24. APOE-epsilon4 and APOE -491A polymorphisms in individuals with subjective memory loss.
Laws SM; Clarnette RM; Taddei K; Martins G; Paton A; Hallmayer J; Almeida OP; Groth DM; Gandy SE; Förstl H; Martins RN
Mol Psychiatry; 2002; 7(7):768-75. PubMed ID: 12192621
[TBL] [Abstract][Full Text] [Related]
25. Effects of medications on plasma amyloid beta (Abeta) 42: longitudinal data from the VITA cohort.
Blasko I; Jungwirth S; Jellinger K; Kemmler G; Krampla W; Weissgram S; Wichart I; Tragl KH; Hinterhuber H; Fischer P
J Psychiatr Res; 2008 Sep; 42(11):946-55. PubMed ID: 18155247
[TBL] [Abstract][Full Text] [Related]
26. Association between enzymatic and non-enzymatic antioxidant defense mechanism with apolipoprotein E genotypes in Alzheimer disease.
Kharrazi H; Vaisi-Raygani A; Rahimi Z; Tavilani H; Aminian M; Pourmotabbed T
Clin Biochem; 2008 Aug; 41(12):932-6. PubMed ID: 18505684
[TBL] [Abstract][Full Text] [Related]
27. Association study and meta-analysis of Alzheimer's disease risk and presenilin-1 intronic polymorphism.
Rodríguez-Manotas M; Amorín-Díaz M; Cañizares-Hernández F; Ruíz-Espejo F; Martínez-Vidal S; González-Sarmiento R; Martínez-Hernández P; Cabezas-Herrera J
Brain Res; 2007 Sep; 1170():119-28. PubMed ID: 17719017
[TBL] [Abstract][Full Text] [Related]
28. Association of RFC1 A80G and MTHFR C677T polymorphisms with Alzheimer's disease.
Bi XH; Zhao HL; Zhang ZX; Zhang JW
Neurobiol Aging; 2009 Oct; 30(10):1601-7. PubMed ID: 18258338
[TBL] [Abstract][Full Text] [Related]
29. No association between alpha-1-antichymotrypsin polymorphism and Alzheimer's disease in Koreans.
Kim KW; Jhoo JH; Lee KU; Lee DY; Lee JH; Youn JY; Lee BJ; Han SH; Woo JI
Am J Med Genet; 2000 Apr; 91(5):355-8. PubMed ID: 10766998
[TBL] [Abstract][Full Text] [Related]
30. Cystatin C and apoe polymorphisms in Italian Alzheimer's disease.
Nacmias B; Bagnoli S; Tedde A; Cellini E; Guarnieri BM; Bartoli A; Serio A; Piacentini S; Sorbi S
Neurosci Lett; 2006 Jan; 392(1-2):110-3. PubMed ID: 16188386
[TBL] [Abstract][Full Text] [Related]
31. Genetic interaction between tau and the apolipoprotein E receptor LRP1 Increases Alzheimer's disease risk.
Vázquez-Higuera JL; Mateo I; Sánchez-Juan P; Rodríguez-Rodríguez E; Pozueta A; Infante J; Berciano J; Combarros O
Dement Geriatr Cogn Disord; 2009; 28(2):116-20. PubMed ID: 19684401
[TBL] [Abstract][Full Text] [Related]
32. Anatomically-distinct genetic associations of APOE epsilon4 allele load with regional cortical atrophy in Alzheimer's disease.
Filippini N; Rao A; Wetten S; Gibson RA; Borrie M; Guzman D; Kertesz A; Loy-English I; Williams J; Nichols T; Whitcher B; Matthews PM
Neuroimage; 2009 Feb; 44(3):724-8. PubMed ID: 19013250
[TBL] [Abstract][Full Text] [Related]
33. Amyloid-β 1-42 levels are modified by apolipoprotein E ε4 in Creutzfeldt-Jakob disease in a similar manner as in Alzheimer's disease.
Varges D; Jung K; Gawinecka J; Heinemann U; Schmitz M; von Ahsen N; Krasnianski A; Armstrong VW; Zerr I
J Alzheimers Dis; 2011; 23(4):717-26. PubMed ID: 21157024
[TBL] [Abstract][Full Text] [Related]
34. Association of IL10 promoter polymorphism in Italian Alzheimer's disease.
Bagnoli S; Cellini E; Tedde A; Nacmias B; Piacentini S; Bessi V; Bracco L; Sorbi S
Neurosci Lett; 2007 May; 418(3):262-5. PubMed ID: 17420099
[TBL] [Abstract][Full Text] [Related]
35. The APOC3 SstI polymorphism is weakly associated with sporadic Alzheimer's disease in a Chinese population.
Sun Y; Shi J; Zhang S; Tang M; Han H; Guo Y; Ma C; Liu X; Li T
Neurosci Lett; 2005 Jun; 380(3):219-22. PubMed ID: 15862889
[TBL] [Abstract][Full Text] [Related]
36. Association study of the GAB2 gene with the risk of developing Alzheimer's disease.
Chapuis J; Hannequin D; Pasquier F; Bentham P; Brice A; Leber I; Frebourg T; Deleuze JF; Cousin E; Thaker U; Amouyel P; Mann D; Lendon C; Campion D; Lambert JC
Neurobiol Dis; 2008 Apr; 30(1):103-6. PubMed ID: 18272374
[TBL] [Abstract][Full Text] [Related]
37. Elevated amyloid beta protein (Abeta42) and late onset Alzheimer's disease are associated with single nucleotide polymorphisms in the urokinase-type plasminogen activator gene.
Ertekin-Taner N; Ronald J; Feuk L; Prince J; Tucker M; Younkin L; Hella M; Jain S; Hackett A; Scanlin L; Kelly J; Kihiko-Ehman M; Neltner M; Hersh L; Kindy M; Markesbery W; Hutton M; de Andrade M; Petersen RC; Graff-Radford N; Estus S; Brookes AJ; Younkin SG
Hum Mol Genet; 2005 Feb; 14(3):447-60. PubMed ID: 15615772
[TBL] [Abstract][Full Text] [Related]
38. Rapid detection of apolipoprotein E genotypes in Alzheimer's disease using polymerase chain reaction-single strand conformation polymorphism.
Kamruecha W; Chansirikarnjana S; Nimkulrat E; Udommongkol C; Wongmek W; Thangnipon W
Southeast Asian J Trop Med Public Health; 2006 Jul; 37(4):793-7. PubMed ID: 17121308
[TBL] [Abstract][Full Text] [Related]
39. Association between apolipoprotein E polymorphism and serum lipid and apolipoprotein levels with Alzheimer's disease.
Raygani AV; Rahimi Z; Kharazi H; Tavilani H; Pourmotabbed T
Neurosci Lett; 2006 Nov; 408(1):68-72. PubMed ID: 16997467
[TBL] [Abstract][Full Text] [Related]
40. No association of CSF biomarkers with APOEepsilon4, plaque and tangle burden in definite Alzheimer's disease.
Engelborghs S; Sleegers K; Cras P; Brouwers N; Serneels S; De Leenheir E; Martin JJ; Vanmechelen E; Van Broeckhoven C; De Deyn PP
Brain; 2007 Sep; 130(Pt 9):2320-6. PubMed ID: 17586559
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
